If this is where you are…
If a page displays a government code or an official-looking badge, ask what it proves. A code is not an answer about the finished medicine.
Approval belongs to a particular product
Mounjaro and Zepbound (tirzepatide) were approved products in September 2026, as were Ozempic and Wegovy (semaglutide); the approving agency was the Food and Drug Administration (FDA).[a]
In September 2026, these approvals do not cover every medicine made with those ingredients.[d]
Ask for the product name, its form, and the reason it is being considered for your health problem.
A directory code does not prove approval
A product’s entry in a drug directory is identified by its National Drug Code, or NDC.[b]
The FDA says a directory code does not prove it approved the medicine or checked the information in the entry, as of September 2026.[b]
Ask for the actual approval record instead of taking a directory entry as the final answer.
Research labels need a separate check
BPC-157 and ipamorelin have no FDA-approved U.S. medicines, based on the approval search checked in September 2026.[a]
That search tells you whether a medicine is approved; separate federal rules decide whether a pharmacy may make it to order.[a]
BPC-157 fails the federal ingredient tests for an ordinary pharmacy making medicine to order, according to FDA documents checked in September 2026.[e]
For ipamorelin acetate, the September 2026 sources did not show that a pharmacy has a legal route to make it to order.[e]
That is a reading of the checked rules and sources, rather than a separate FDA finding that this ingredient fails the tests.[e]
Ask the pharmacy which rule permits the exact ingredient in your proposed medicine.
A research-only label does not give permission to sell a product for treatment.[c]
In letters checked in September 2026, the FDA said sellers broke drug law by offering unapproved products for people to use, despite research-only labels.[c]
A warning letter states the agency’s allegations at that point; it is not a court judgment.[c]
A government directory entry can name an ingredient without approving a medicine made from it.[b]
Keep the proposed medicine’s exact name. Ask whoever treats you why it is being considered and whether it can legally be supplied.